We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)

    Oral drugs such as ibrutinib play an important role in the treatment of mature B-cell lymphoma (BCL) due to their reliable efficacy, manageable...

    Suning Chen, Weili Zhao, ... Depei Wu in Frontiers of Medicine
    Article 24 September 2022
  2. Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma

    Background

    The combination of rituximab and chemotherapy is a first-line treatment for patients with B-cell non-Hodgkin lymphoma. Lenalidomide is an...

    Yang Liu, Yanju Li, ... Feiqing Wang in Discover Oncology
    Article Open access 05 April 2024
  3. Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response

    Background

    Lymphoma is the most common primary hematological malignancy. FDG PET/CT has recently become the standard imaging modality for clinical...

    Salma M. Borg, Gehad A. Saleh, ... Amani Ezzat Mousa in Egyptian Journal of Radiology and Nuclear Medicine
    Article Open access 12 April 2024
  4. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives

    Intraocular lymphoma (IOL) is a rare malignant intraocular lymphocytic tumor that mimics uveitis. IOL is anatomically classified into vitreoretinal...

    Toshikatsu Kaburaki, Kazuki Taoka in Japanese Journal of Ophthalmology
    Article 20 May 2023
  5. Intraoral CD30+ T-Cell Lymphoproliferative Disorder with Lymphomatoid Papulosis Type C Features Mimics Lymphoma Histopathologically and Immunohistochemically

    Background

    Previous studies have shown that at least a of intraoral eosinophilic ulcer is best classified as a CD30 + T-cell lymphoproliferative...

    Camila Oliveira Barbeiro, Heitor Albergoni Silveira, ... Jorge Esquiche León in Head and Neck Pathology
    Article 28 June 2024
  6. Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

    Purpose

    Lorlatinib is a third-generation tyrosine kinase inhibitor currently approved for the treatment of anaplastic lymphoma kinase (ALK)-positive...

    Jennifer E. Hibma, Melissa O’Gorman, ... Yazdi K. Pithavala in Cancer Chemotherapy and Pharmacology
    Article Open access 26 October 2021
  7. Adult T-cell Leukemia/Lymphoma (ATL) in the Nasal and Paranasal Cavity: Four Cases Report

    Adult T-cell leukemia/lymphoma (ATL) is a form of leukemia caused by the human T-cell leukemia virus type I (HTLV-1). Otolaryngologists often...

    Hiromi Nagano, Hayato Matsumoto, ... Masaru Yamashita in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 13 October 2023
  8. Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma

    This registration study assessed clinical outcomes of TQ-B3525, the dual phosphatidylinositol-3-kinase (PI3K) α/δ inhibitor, in relapsed and/or...

    Huaqing Wang, Jifeng Feng, ... Zhiming Li in Signal Transduction and Targeted Therapy
    Article Open access 17 April 2024
  9. In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma

    Non-Hodgkin lymphoma (NHL) is one of the most common cancer types. Deregulated signaling pathways can trigger certain NHL subtypes, including Diffuse...

    Abas Sezer, Lejla Mahmutović, Betül Akçeşme in Medical Oncology
    Article 28 December 2023
  10. Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report

    Background

    Papillary thyroid carcinoma (PTC) stands out as the most prevalent epithelial malignant thyroid tumor. Thyroid primary follicular lymphoma...

    Ting Xu, Li Wu, ... ****g Wang in Diagnostic Pathology
    Article Open access 21 May 2024
  11. Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a sco** review

    Purpose

    We undertook a sco** review of the literature to synthesize what is known about lymphoma survivorship and develop a comprehensive set of...

    Melanie Powis, Saidah Hack, ... Vishal Kukreti in Journal of Cancer Survivorship
    Article 04 December 2023
  12. Role of EBUS in lymphoma presenting as superior vena cava syndrome: bronchoscopic and sonographic findings: a case report

    Background

    The clinical description of superior vena cava syndrome has been widely studied; however, there is limited information on bronchoscopic...

    Ancy Elsa Thomas, Balamugesh Thangakunam, ... Thomas Alex Kodiatte in The Egyptian Journal of Bronchology
    Article Open access 03 June 2024
  13. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma

    Peripheral T cell lymphoma (PTCL) represents a group of heterogeneous hematological malignancies, which are notoriously challenging to treat and...

    Esther Wei Yin Chang, Ya Hwee Tan, Jason Yongsheng Chan in Journal of Hematology & Oncology
    Article Open access 01 June 2024
  14. Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report

    Background

    Nivolumab is an immune checkpoint inhibitor that targets the programmed cell death-1 protein and is effective in treating advanced cancer....

    Chulmin Park, Kyoung Tae Kim in BMC Neurology
    Article Open access 30 March 2023
  15. Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions

    Adult T-cell leukemia/lymphoma (ATL) is a rare, aggressive subtype of peripheral T-cell lymphoma develo** after many years of chronic, asymptomatic...

    Robert Stuver, Steven M. Horwitz, Zachary D. Epstein-Peterson in Current Treatment Options in Oncology
    Article 10 June 2023
  16. Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing

    Purpose

    Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a relatively rare subtype of DLBCL. Herein, we report a case of a...

    Article Open access 04 March 2024
  17. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review

    Adult T-cell leukemia/lymphoma (ATLL), an infrequent malignancy resultant from human T-cell lymphotropic virus type I (HTLV-1), exhibits a spectrum...

    Arash Letafati, Roben Soheili, ... Sayed-Hamidreza Mozhgani in Medical Oncology
    Article 09 September 2023
  18. Notch signaling in oral pre-cancer and oral cancer

    Notch signaling involves cell to cell contact. It is an ancient signaling mechanism that is conserved throughout the animal kingdom. The basic...

    Kumud Nigam, Ratnesh Kumar Srivastav in Medical Oncology
    Article 11 October 2021
  19. What Is New in Cutaneous T Cell Lymphoma?

    Purpose of Review

    This review focuses on updates in prognosis, pathogenesis, and treatment of cutaneous T cell lymphoma (CTCL).

    Recent Findings ...
    Sarah Morgenroth, Andrea Roggo, ... Egle Ramelyte in Current Oncology Reports
    Article Open access 24 October 2023
  20. An unusual case of lymphoma — a case of extranodal NK/T-cell lymphoma, nasal type

    Background

    There is a great geographic variation of extranodal natural killer (NK)/T-cell lymphoma, nasal type (NNKTL) prevalence, with a much higher...

    Mahlatse Mankgele, Lindokuhle Goqwana, ... Moosa Patel in The Egyptian Journal of Otolaryngology
    Article Open access 04 September 2022
Did you find what you were looking for? Share feedback.